NCT02309008View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2016

Conditions
Healthy
Interventions
DRUG

PAC-14028

Participants will receive PAC-14028 cream applied topically once a day for 9 days

OTHER

Vehicle

Participants will receive vehicle cream applied topically once a day for 9 days

Trial Locations (1)

110-744

Seoul National University Hospital Clinical Trials Center, Seoul

All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

lead

Amorepacific Corporation

INDUSTRY

NCT02309008 - A Study to Assess the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream in Healthy Male Subjects | Biotech Hunter | Biotech Hunter